Effect of 12-weeks elastic band resistance training on MyomiRs and osteoporosis markers in elderly women with Osteosarcopenic obesity: a randomized controlled trial.


Journal

BMC geriatrics
ISSN: 1471-2318
Titre abrégé: BMC Geriatr
Pays: England
ID NLM: 100968548

Informations de publication

Date de publication:
20 07 2021
Historique:
received: 24 03 2021
accepted: 02 07 2021
entrez: 21 7 2021
pubmed: 22 7 2021
medline: 10 8 2021
Statut: epublish

Résumé

Interorgan communication networks established during exercise in several different tissues can be mediated by several exercise-induced factors. Therefore, the present study aimed to investigate the effects of resistance-type training using elastic band-induced changes of myomiRs (i.e., miR-206 and miR-133), vitamin D, CTX-I, ALP, and FRAX® score in elderly women with osteosarcopenic obesity (OSO). In this randomized controlled trial, 63 women (aged 65-80 years) with Osteosarcopenic Obesity were recruited and assessed, using a dual-energy X-ray absorptiometry instrument. The resistance-type training via elastic bands was further designed three times per week for 12-weeks. The main outcomes were Fracture Risk Assessment Tool score, bone mineral content, bone mineral density, vitamin D, alkaline phosphatase, C-terminal telopeptides of type I collagen, expression of miR-206 and miR-133. There was no significant difference between the study groups in terms of the Fracture Risk Assessment Tool score (p = 0.067), vitamin D (p = 0.566), alkaline phosphatase (p = 0.334), C-terminal telopeptides of type I collagen (p = 0.067), microR-133 (p = 0.093) and miR-206 (p = 0.723). Overall, the results of this study illustrated 12-weeks of elastic band resistance training causes a slight and insignificant improvement in osteoporosis markers in women affected with Osteosarcopenic Obesity. Randomized controlled trial (RCT) (Iranian Registry of Clinical Trials, trial registration number: IRCT20180627040260N1 . Date of registration: 27/11/2018.

Sections du résumé

BACKGROUND
Interorgan communication networks established during exercise in several different tissues can be mediated by several exercise-induced factors. Therefore, the present study aimed to investigate the effects of resistance-type training using elastic band-induced changes of myomiRs (i.e., miR-206 and miR-133), vitamin D, CTX-I, ALP, and FRAX® score in elderly women with osteosarcopenic obesity (OSO).
METHODS
In this randomized controlled trial, 63 women (aged 65-80 years) with Osteosarcopenic Obesity were recruited and assessed, using a dual-energy X-ray absorptiometry instrument. The resistance-type training via elastic bands was further designed three times per week for 12-weeks. The main outcomes were Fracture Risk Assessment Tool score, bone mineral content, bone mineral density, vitamin D, alkaline phosphatase, C-terminal telopeptides of type I collagen, expression of miR-206 and miR-133.
RESULTS
There was no significant difference between the study groups in terms of the Fracture Risk Assessment Tool score (p = 0.067), vitamin D (p = 0.566), alkaline phosphatase (p = 0.334), C-terminal telopeptides of type I collagen (p = 0.067), microR-133 (p = 0.093) and miR-206 (p = 0.723).
CONCLUSION
Overall, the results of this study illustrated 12-weeks of elastic band resistance training causes a slight and insignificant improvement in osteoporosis markers in women affected with Osteosarcopenic Obesity.
TRIAL REGISTRATION
Randomized controlled trial (RCT) (Iranian Registry of Clinical Trials, trial registration number: IRCT20180627040260N1 . Date of registration: 27/11/2018.

Identifiants

pubmed: 34284726
doi: 10.1186/s12877-021-02374-9
pii: 10.1186/s12877-021-02374-9
pmc: PMC8290586
doi:

Substances chimiques

MIRN206 microRNA, human 0
MicroRNAs 0

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

433

Informations de copyright

© 2021. The Author(s).

Références

J Phys Act Health. 2017 Apr;14(4):317-327
pubmed: 28032811
Endocrine. 2014 Mar;45(2):165-77
pubmed: 23990248
J Bone Miner Res. 2014 Mar;29(3):644-56
pubmed: 23929739
BMJ Open. 2016 Sep 30;6(9):e012140
pubmed: 27694489
Nutr Res. 2017 Jul;43:3-15
pubmed: 28739051
J Burn Care Res. 2017 Jan/Feb;38(1):11-19
pubmed: 27753701
Cell Cycle. 2014;13(1):78-89
pubmed: 24196440
Front Physiol. 2013 Apr 11;4:80
pubmed: 23596423
Endocrinology. 2013 Sep;154(9):3344-52
pubmed: 23798596
Aging (Albany NY). 2019 Mar 25;11(6):1791-1803
pubmed: 30910993
J Physiol. 2013 Sep 15;591(18):4637-53
pubmed: 23798494
Curr Genomics. 2015 Dec;16(6):441-52
pubmed: 27019619
Exp Gerontol. 2020 Jul 1;135:110884
pubmed: 32092502
Nutrients. 2019 Mar 30;11(4):
pubmed: 30935031
J Appl Physiol (1985). 2011 Feb;110(2):309-17
pubmed: 21030674
Int J Mol Sci. 2017 Jul 14;18(7):
pubmed: 28708070
Bone. 2015 Oct;79:43-51
pubmed: 26026730
Endokrynol Pol. 2018;69(2):142-149
pubmed: 29465155
Bone. 2017 Nov;104:101-105
pubmed: 28625918
J Bone Miner Res. 2015 Feb;30(2):330-45
pubmed: 25195535
Curr Opin Clin Nutr Metab Care. 2013 May;16(3):258-66
pubmed: 23449000
PLoS One. 2017 Apr 20;12(4):e0176161
pubmed: 28426779
J Bone Miner Res. 1995 Oct;10(10):1544-9
pubmed: 8686511
Genes Nutr. 2017 Sep 25;12:23
pubmed: 28974990
Front Nutr. 2018 Jan 09;4:69
pubmed: 29376055
Int J Mol Sci. 2018 Jan 30;19(2):
pubmed: 29385720
Front Physiol. 2017 Jun 07;8:383
pubmed: 28638346
BMC Musculoskelet Disord. 2016 Jun 08;17:254
pubmed: 27278385
Curr Osteoporos Rep. 2011 Dec;9(4):237-42
pubmed: 21858507
Mol Cell Endocrinol. 2016 Sep 5;432:83-95
pubmed: 26525415
Biomed Eng Online. 2016 Apr 22;15:43
pubmed: 27103394
Curr Osteoporos Rep. 2019 Dec;17(6):548-559
pubmed: 31741222
J Physiol. 2010 Oct 15;588(Pt 20):4029-37
pubmed: 20724368
J Bone Miner Res. 2013 Jul;28(7):1509-18
pubmed: 23630111
Curr Mol Med. 2011 Jun;11(4):304-16
pubmed: 21506921
Cold Spring Harb Perspect Med. 2017 Nov 1;7(11):
pubmed: 28389517
Am J Physiol Heart Circ Physiol. 2018 Aug 1;315(2):H273-H283
pubmed: 29600898
Oncotarget. 2018 Mar 30;9(24):17220-17237
pubmed: 29682218
J Sports Sci. 2018 Jul;36(14):1564-1571
pubmed: 29125017
J Physiol Anthropol. 2018 Jul 31;37(1):19
pubmed: 30064499
J Am Med Dir Assoc. 2017 Aug 1;18(8):648-650
pubmed: 28623150
World J Biol Chem. 2015 Aug 26;6(3):162-208
pubmed: 26322174
J Strength Cond Res. 2012 Nov;26(11):3018-24
pubmed: 22210471
Curr Gerontol Geriatr Res. 2016;2016:7325973
pubmed: 27667996

Auteurs

Ebrahim Banitalebi (E)

Department of Sport Sciences, Shahrekord University, Shahrekord, Iran.

Majid Mardaniyan Ghahfarrokhi (MM)

Department of Sport Sciences, Shahrekord University, Shahrekord, Iran.

Mortaza Dehghan (M)

Clinical Research Development Unit, Kashani Hospital, Shahrekord University of Medical Sciences, Shahrekord, Iran. dehghan_mortaza@yahoo.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH